Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-May-2025 11:08 ET (1-May-2025 15:08 GMT/UTC)
A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic lethal marker for enhancing the efficacy of ATM inhibitors in pancreatic cancer treatment. This innovative research provides a groundbreaking approach to targeting a tumor suppressor gene, BEND4, which is frequently methylated and silenced in pancreatic cancer. The study delves into the role of BEND4 in DNA damage repair and its potential as a therapeutic marker when combined with ATM inhibitor treatment.
An advanced aqueous battery design incorporating photothermal technology enables rapid self-heating, making it well-suited for low-temperature environments. The battery uses photothermal current collectors to convert sunlight into heat, which is efficiently distributed throughout the system by high-conductivity suspension electrodes. This design mitigates common cold-climate challenges such as electrolyte freezing and slow ion transfer, ensuring stable performance in sub-zero conditions.
This paper reviews the thermal design of SiC power modules for EV motor drives, focusing on optimizing irregular Pinfin structures to enhance heat dissipation. It proposes a collaborative thermal design approach involving DC bus capacitors and motors, aiming to improve overall heat management and support the development of high power density motor drives.
Personalized education, powered by educational technology and AI, is revolutionizing learning experiences in the digital age. This review examines recent advancements in personalized educational data mining across four key areas: educational recommendation, cognitive diagnosis, knowledge tracing, and learning analysis. The paper presents a structured taxonomy, compile datasets, and identify future research directions, highlighting data mining’s pivotal role in optimizing learning processes, and fostering innovation in personalized education.
In this paper, we consider the scenario where the prover of zk-SNARK delegates its proving power to other parties.
In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma (HCC), a recent study has identified a pivotal role for CD39 expression in modulating the function of CAR-T cells. The research, conducted by a team of scientists, investigated the impact of CD39 modulation on CAR-T cells, hypothesizing that optimal levels of CD39 could boost the therapeutic potential of these cells against HCC. The study utilized a combination of in vitro and in vivo experiments, including the use of a subcutaneous HCC mouse model, to demonstrate that CAR-T cells with moderate CD39 expression levels displayed superior antitumor activity compared to those with high or low CD39 levels. Furthermore, the study explored the use of mdivi-1, a small molecule inhibitor, to modulate CD39 expression, revealing a synergistic effect when combined with CD39 knockdown that significantly enhanced the antitumor response.